What happened
EuBiologics updated the disclosed terms of an acquisition, now worth US$10.1M.
For context, this deal is worth about 6.2% of the company's own total assets.
| Target | Disclosed |
|---|---|
| Deal value | US$10.1M |
| vs. company assets | 6.2% |
| Filed | 2026-04-22, [Amended] Decision to acquire shares/equity in another company |
| Source | DART rcept 20260422900674 → open original filing |
Source: DART. Information only, not investment advice.